216 related articles for article (PubMed ID: 8796141)
1. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
Guido M; Ciampelli M; Fulghesu AM; Pavone V; Barini A; de Marinis L; Cento R; Caruso A; Lanzone A
Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
[TBL] [Abstract][Full Text] [Related]
3. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ; Prickett TC; Mulder RT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[TBL] [Abstract][Full Text] [Related]
4. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
5. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
6. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
Milutinović DV; Macut D; Božić I; Nestorov J; Damjanović S; Matić G
Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
[TBL] [Abstract][Full Text] [Related]
8. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Lizcano F; Salvador J
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
[TBL] [Abstract][Full Text] [Related]
9. Disturbed stress responses in women with polycystic ovary syndrome.
Benson S; Arck PC; Tan S; Hahn S; Mann K; Rifaie N; Janssen OE; Schedlowski M; Elsenbruch S
Psychoneuroendocrinology; 2009 Jun; 34(5):727-35. PubMed ID: 19150179
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.
Ciampelli M; Guido M; Cucinelli F; Cinque B; Barini A; Lanzone A
Fertil Steril; 2000 Apr; 73(4):712-7. PubMed ID: 10731530
[TBL] [Abstract][Full Text] [Related]
11. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
13. Impact of maternal undernutrition on the hypothalamic-pituitary-adrenal axis responsiveness in sheep at different ages postnatal.
Chadio SE; Kotsampasi B; Papadomichelakis G; Deligeorgis S; Kalogiannis D; Menegatos I; Zervas G
J Endocrinol; 2007 Mar; 192(3):495-503. PubMed ID: 17332519
[TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropic hormone/cortisol response to physical exercise in abstinent alcoholic patients.
Coiro V; Casti A; Jotti GS; Rubino P; Manfredi G; Maffei ML; Melani A; Volta E; Chiodera P
Alcohol Clin Exp Res; 2007 May; 31(5):901-6. PubMed ID: 17386066
[TBL] [Abstract][Full Text] [Related]
15. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
[TBL] [Abstract][Full Text] [Related]
16. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
Dekkers JC; Geenen R; Godaert GL; Glaudemans KA; Lafeber FP; van Doornen LJ; Bijlsma JW
J Rheumatol; 2001 Jul; 28(7):1496-504. PubMed ID: 11469453
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
Lanzone A; Fulghesu AM; Guido M; Cucinelli F; Caruso A; Mancuso S
Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
[TBL] [Abstract][Full Text] [Related]
18. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
[TBL] [Abstract][Full Text] [Related]
19. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
Ryan MC; Sharifi N; Condren R; Thakore JH
Psychoneuroendocrinology; 2004 Sep; 29(8):1065-70. PubMed ID: 15219658
[TBL] [Abstract][Full Text] [Related]
20. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
